327 Maternal B-12 supplementation in vegetarian pregnant women improves maternal B-12 status and infant neurodevelopment: The MATCOBIND multi-centric double-blind randomised-control-trial
327 Maternal B-12 supplementation in vegetarian pregnant women improves maternal B-12 status and infant neurodevelopment: The MATCOBIND multi-centric double-blind randomised-control-trial
复制标题
327 素食孕妇补充 B-12 可改善母亲 B-12 状态和婴儿神经发育:MATCOBIND 多中心双盲随机对照试验
DOI:
10.1136/archdischild-2023-rcpch.486
复制
发表时间:
2023
期刊:
影响因子:
--
通讯作者:
Nagpal J
中科院分区:
文献类型:
--
作者:
Nagpal J
ObjectivesVitamin B-12 deficiency is common in many low- and low-middle-income countries. Vegetarian dietary practices often contribute to this high prevalence. Several observational studies have documented the association of B-12 deficiency in pregnancy with poor neurodevelopment amongst infants [1,2]. However, clinical trials are few and inconclusive [3,4]. Hence, the current clinical trial proposed to evaluate the efficacy of maternal B-12 supplementation in vegetarian pregnant women for improving-Infant neurodevelopment at 9 months of ageBiochemical B-12 status in mothers at the end of 3rd trimester and in infants at 9 monthsMethodsThis multi-center, double-blind, randomized controlled trial enrolled 708 vegetarian women in their first trimester from tertiary care facilities in New Delhi, India (n=370) and Kathmandu, Nepal (n=338). Mothers were randomized to receive oral methyl-cobalamin supplementation (250 mcg (Group-A) or 50 mcg (Group-B; quasi-control)) from enrollment to 6-months postpartum as daily capsules. Anthropometry, interval/current morbidity, medical advice (medicines/supplements), and dietary intake were recorded at the facility visits of the mother and infant through pregnancy, childbirth, and infancy. Infant neurodevelopment at 9 months was assessed using the Development Assessment Scale of Indian Infants[5] and the home environment was evaluated using the Bradley HOME inventory[6]. Change in maternal B-12 status between enrollment and the 3rd trimester, and infant B-12 status at 9 months of age were estimated.Results531 subjects completed the study (177 lost to follow-up; comparable for baseline characteristics). The two groups were similar for baseline characteristics (Group-A n=255; Group-B n=276; p>0.05). Table 1 summarizes the outcomes. As presented mean increase in maternal B-12 levels between 1st and 3rd trimester was greater in Group-A (mean, SD): 104.9[159.1] than Group-B 47.5[118.0] pg/ml; p<0.01. Similar improvements were noted in Holo-TC levels (p<0.01) while the changes in Serum Ferritin, Vitamin-D and Folate were similar between the two groups (p>0.05) as expected. Newborn anthropometry, morbidity profiles and APGAR Scores were similar between the two groups (p>0.05). Milk feeding, complementary feeding, interval morbidity, growth and HOME scores were also comparable between the two groups (p>0.05). Mental Developmental Quotient(DQ) was higher in Group-A: 103.7[7.7] vs. Group-B: 101.7[8.8]; p<0.01) corresponding to a mean difference of 7.8 centiles (p<0.01). Mean Motor DQ, infant B-12 status and newborn and infant anthropometry were similar between the two groups (p>0.05).ConclusionMaternal B-12 status improvement and Mental DQ at 9 months are statistically significantly better with 250 mcg/d B-12 supplementation of vegetarian pregnant women compared with 50 mcg/d.ReferencesDror DK, Allen LH. Effect of vitamin B12 deficiency on neurodevelopment in infants: Current knowledge and possible mechanisms Vol. 66,Nutrition Reviews. 2008:250–5.Sklar R. Nutritional vitamin B12 deficiency in a breast-fed infant of a vegan-diet mother.Clin Pediatr (Phila)1986;25(4):219–21.Srinivasan K, Thomas T, Kapanee ARM, Ramthal A, Bellinger DC, Bosch RJ,et al. Effects of maternal vitamin B12 supplementation on early infant neurocognitive outcomes: a randomized controlled clinical trial.Matern Child Nutr.2016;doi: 10.1111/mcn.12325.Siddiqua TJ, Ahmad SM, Ahsan KB, Rashid M, Roy A, Rahman SM,et al. Vitamin B12 supplementation during pregnancy and postpartum improves B12 status of both mothers and infants but vaccine response in mothers …